Simpson Thacher & Bartlett has won a trophy client off the back of its highly-rated Tokyo office – advising drugs giant Merck on its $1.5bn purchase of 49% of Banya Pharmaceutical.

Simpson Thacher’s Japan managing partner David Sneider teamed up with New York partner Alan Klein on the deal, which highlights the attractiveness of Japan’s $50bn pharmaceutical market to foreign companies.